| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.29▼ | 5.27▼ | 5.23▲ | 5.43▼ | 5.43▼ |
| MA10 | 5.27▼ | 5.29▼ | 5.33▼ | 5.22▲ | 7.36▼ |
| MA20 | 5.45▼ | 5.47▼ | 5.48▼ | 4.85▲ | 9.56▼ |
| MA50 | 5.58▼ | 5.24▲ | 5.03▲ | 7.59▼ | 7.61▼ |
| MA100 | 5.00▲ | 4.60▲ | 4.77▲ | 9.44▼ | N/A |
| MA200 | 4.55▲ | 6.22▼ | 6.91▼ | 7.90▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.019▼ | -0.053▼ | -0.073▼ | 0.286▲ | N/A |
| RSI | 39.337▼ | 45.943▼ | 48.030▼ | 43.766▼ | N/A |
| STOCH | 41.022 | 27.400 | 18.905▼ | 76.995 | 12.128▼ |
| WILL %R | -72.131 | -72.131 | -72.131 | -26.190 | -82.805▼ |
| CCI | -43.346 | -46.845 | -50.851 | 53.611 | -94.469 |
|
Friday, April 03, 2020 11:51 PM
Aravive Inc (NASDAQ:ARAV) – Equities researchers at Wedbush issued their Q1 2020 earnings per share (EPS) estimates for shares of Aravive in a report released on Monday, March 30th. Wedbush analyst D.
|
|
Friday, April 03, 2020 02:00 AM
Aravive Inc (NASDAQ:ARAV) – Equities researchers at Wedbush issued their FY2024 earnings per share (EPS) estimates for shares of Aravive in a research report issued to clients and investors on Monday, ...
|
|
Monday, March 30, 2020 03:57 AM
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/04/20 | 5.17 | 5.67 | 5.02 | 5.37 | 82,200 |
| 02/04/20 | 5.15 | 5.47 | 5.00 | 5.18 | 44,600 |
| 01/04/20 | 5.75 | 5.75 | 5.04 | 5.18 | 50,300 |
| 31/03/20 | 5.67 | 6.00 | 5.57 | 5.76 | 68,600 |
| 30/03/20 | 5.94 | 6.02 | 5.46 | 5.66 | 91,200 |
| 27/03/20 | 4.95 | 6.03 | 4.80 | 5.86 | 131,000 |
| 26/03/20 | 5.31 | 5.46 | 5.02 | 5.35 | 103,900 |
| 25/03/20 | 4.59 | 5.32 | 4.37 | 5.30 | 120,600 |
| 24/03/20 | 4.21 | 4.65 | 4.12 | 4.52 | 104,300 |
| 23/03/20 | 3.65 | 4.14 | 3.65 | 4.03 | 179,100 |
|
|
||||
|
|
||||
|
|